최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.29 no.2, 2019년, pp.101 - 108
윤혜원 (연세대학교 의과대학 세브란스병원 약무국) , 이윤선 (연세대학교 의과대학 세브란스병원 약무국) , 송효숙 (연세대학교 의과대학 세브란스병원 약무국) , 김재송 (연세대학교 의과대학 세브란스병원 약무국) , 손은선 (연세대학교 의과대학 세브란스병원 약무국)
Background: High doses of methotrexate (MTX) are often used in various chemotherapy protocols to treat acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL) in children, but its delayed elimination increases the occurrence of adverse events, such as bone marrow suppression. The aim of ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
methotrexate란? | 고용량 methotrexate (MTX)는 소아 급성림프모구백혈병(acute lymphoblastic leukemia, ALL) 및 비호지킨림프종(non-Hodgkin lymphoma, NHL) 치료의 중요한 약물이다.1) MTX의 용량은 2. | |
고용량 MTX의 부작용은 무엇인가? | 고용량 MTX가 투여될 경우 골수억제, 신독성, 간독성, 위장관계 점막염, 신경독성 등이 나타날 수 있으며, 특히 배설지연이 일어날 경우 골수억제 등의 부작용이 심각해질 수 있다.3,4) MTX는 dihydrofolate reductase (DHFR)를 가역적으로 억제함으로써 dihydrofolates (FH2)로부터 핵산 합성에 필수적인tetrahydrofolate (FH4)가 만들어지는 것을 저해하여 항암효과를 나타낸다. | |
고용량 methotrexate라고 정의하는 MTX의 용량은 어느정도인가? | 1) MTX의 용량은 2.5 mg부터 12 g/m2까지 적응증 및 치료요법에 따라 다양하게 사용되며, 일반적으로 1g/m2 이상일 경우고용량 MTX 라고 정의한다.2) |
Csordas, Katalin, Hegyi, Marta, Eipel, Oliver T., Muller, Judit, Erdelyi, Daniel J., Kovacs, Gabor T.. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Anti-cancer drugs, vol.24, no.2, 189-197.
Cerminara, Zak, Duffy, Alison, Nishioka, Jennifer, Trovato, James, Gilmore, Steven. A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.25, no.1, 76-84.
Xu, Weiqun, Tang, Yongmin, Song, Hua, Shi, Shuwen, Yang, Shilong. Retrospective Study on Elimination Delay of Methotrexate in High-dose Therapy of Childhood Acute Lymphoblastic Leukemia in China. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, vol.29, no.10, 688-693.
Howard, Scott C., McCormick, John, Pui, Ching-Hon, Buddington, Randall K., Harvey, R. Donald. Preventing and Managing Toxicities of High-Dose Methotrexate. The oncologist, vol.21, no.12, 1471-1482.
Yanagimachi, Masakatsu, Goto, Hiroaki, Kaneko, Tetsuji, Naruto, Takuya, Sasaki, Koji, Takeuchi, Masanobu, Tanoshima, Reo, Kato, Hiromi, Yokosuka, Tomoko, Kajiwara, Ryosuke, Fujii, Hisaki, Tanaka, Fumiko, Goto, Shoko, Takahashi, Hiroyuki, Mori, Masaaki, Kai, Sumio, Yokota, Shumpei. Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy. International journal of hematology, vol.98, no.6, 702-707.
Larsen, Eric C., Devidas, Meenakshi, Chen, Si, Salzer, Wanda L., Raetz, Elizabeth A., Loh, Mignon L., Mattano Jr, Leonard A., Cole, Catherine, Eicher, Alisa, Haugan, Maureen, Sorenson, Mark, Heerema, Nyla A., Carroll, Andrew A., Gastier-Foster, Julie M., Borowitz, Michael J., Wood, Brent L., Willman, Cheryl L., Winick, Naomi J., Hunger, Stephen P., Carroll, William L.. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.34, no.20, 2380-2388.
Schultz, Kirk R., Bowman, W. Paul, Aledo, Alexander, Slayton, William B., Sather, Harland, Devidas, Meenakshi, Wang, Chenguang, Davies, Stella M., Gaynon, Paul S., Trigg, Michael, Rutledge, Robert, Burden, Laura, Jorstad, Dean, Carroll, Andrew, Heerema, Nyla A., Winick, Naomi, Borowitz, Michael J., Hunger, Stephen P., Carroll, William L., Camitta, Bruce. Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.27, no.31, 5175-5181.
Winter, Stuart S., Dunsmore, Kimberly P., Devidas, Meenakshi, Wood, Brent L., Esiashvili, Natia, Chen, Zhiguo, Eisenberg, Nancy, Briegel, Nikki, Hayashi, Robert J., Gastier-Foster, Julie M., Carroll, Andrew J., Heerema, Nyla A., Asselin, Barbara L., Gaynon, Paul S., Borowitz, Michael J., Loh, Mignon L., Rabin, Karen R., Raetz, Elizabeth A., Zweidler-Mckay, Patrick A., Winick, Naomi J., Carroll, William L., Hunger, Stephen P.. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children’s Oncology Group AALL0434 Methotrexate Randomization. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.36, no.29, 2926-2934.
Reiss, Samantha N., Buie, Larry W., Adel, Nelly, Goldman, Debra A., Devlin, Sean M., Douer, Dan. Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia. Annals of hematology, vol.95, no.12, 2009-2015.
Fabresse, Nicolas, Devictor, Bénédicte, Pissier, Christel, Chambost, Hervé, Lacarelle, Bruno, Michel, Gérard, Solas, Caroline. Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate. Therapeutic drug monitoring, vol.40, no.1, 76-83.
Svahn, Thommy, Mellgren, Karin, Harila‐Saari, Arja, Åsberg, Ann, Kanerva, Jukka, Jónsson, Ólafur, Vaitkeviciene, Goda, Stamm Mikkelssen, Torben, Schmiegelow, Kjeld, Heldrup, Jesper. Delayed elimination of high‐dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia. Pediatric blood & cancer, vol.64, no.7, e26395-.
Bielack, Stefan S., Smeland, Sigbjørn, Whelan, Jeremy S., Marina, Neyssa, Jovic, Gordana, Hook, Jane M., Krailo, Mark D., Gebhardt, Mark, Pápai, Zsuzsanna, Meyer, James, Nadel, Helen, Randall, R. Lor, Deffenbaugh, Claudia, Nagarajan, Rajaram, Brennan, Bernadette, Letson, G. Douglas, Teot, Lisa A., Goorin, Allen, Baumhoer, Daniel, Kager, Leo, Werner, Mathias, Lau, Ching C., Sundby Hall, Kirsten, Gelderblom, Hans, Meyers, Paul, Gorlick, Richard, Windhager, Reinhard, Helmke, Knut, Eriksson, Mikael, Hoogerbrugge, Peter M., Schomberg, Paula, Tunn, Per-Ulf, Kühne, Thomas, Jürgens, Heribert, van den Berg, Henk, Böhling, Tom, Picton, Susan, Renard, Marleen, Reichardt, Peter, Gerss, Joachim, Butterfass-Bahloul, Trude, Morris, Carol, Hogendoorn, Pancras C.W., Seddon, Beatrice, Calaminus, Gabriele, Michelagnoli, Maria, Dhooge, Catharina, Sydes, Matthew R., Bernstein, Mark. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.33, no.20, 2279-2287.
Wiczer, Tracy, Dotson, Emily, Tuten, Amy, Phillips, Gary, Maddocks, Kami. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.22, no.3, 430-436.
Schwartz, George J., Feld, Leonard G., Langford, Daniel J.. A simple estimate of glomerular filtration ratein full-term infants during the first year of life. The Journal of pediatrics, vol.104, no.6, 849-854.
Schwartz, George J., Gauthier, Bernard. A simple estimate of glomerular filtration rate in adolescent boys. The Journal of pediatrics, vol.106, no.3, 522-526.
Bhojwani, Deepa, Sabin, Noah D., Pei, Deqing, Yang, Jun J., Khan, Raja B., Panetta, John C., Krull, Kevin R., Inaba, Hiroto, Rubnitz, Jeffrey E., Metzger, Monika L., Howard, Scott C., Ribeiro, Raul C., Cheng, Cheng, Reddick, Wilburn E., Jeha, Sima, Sandlund, John T., Evans, William E., Pui, Ching-Hon, Relling, Mary V.. Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.32, no.9, 949-959.
Skärby, T., Jönsson, P., Hjorth, L., Behrentz, M., Björk, O., Forestier, E., Jarfelt, M., Lönnerholm, G., Höglund, P.. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL). Cancer chemotherapy and pharmacology, vol.51, no.4, 311-320.
Santucci R, Leveque D, Kemmel V, et al . Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors. Anticancer Res 2010;30(3):963-5.
Ranchon, Florence, Vantard, Nicolas, Henin, Emilie, Bachy, Emmanuel, Sarkozy, Clémentine, Karlin, Lionel, Bouafia‐Sauvy, Fadhela, Gouraud, Aurore, Schwiertz, Verane, Bourbon, Estelle, Baudouin, Amandine, Caffin, Anne Gaelle, Vial, Thierry, Salles, Gilles, Rioufol, Catherine. Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?. Hematological oncology, vol.36, no.2, 399-406.
Ramsey, Laura B., Balis, Frank M., O'Brien, Maureen M., Schmiegelow, Kjeld, Pauley, Jennifer L., Bleyer, Archie, Widemann, Brigitte C., Askenazi, David, Bergeron, Sharon, Shirali, Anushree, Schwartz, Stefan, Vinks, Alexander A., Heldrup, Jesper. Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. The oncologist, vol.23, no.1, 52-61.
Traivaree, Chanchai, Likasitthananon, Napakjira, Monsereenusorn, Chalinee, Rujkijyanont, Piya. The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients. Cancer management and research, vol.10, 4471-4478.
Flombaum, Carlos D., Liu, Dazhi, Yan, Shirley Qiong, Chan, Amelia, Mathew, Sherry, Meyers, Paul A., Glezerman, Ilya G., Muthukumar, Thangamani. Management of Patients with Acute Methotrexate Nephrotoxicity with High‐Dose Leucovorin. Pharmacotherapy, vol.38, no.7, 714-724.
Cohen, Ian J.. Defining the Appropriate Dosage of Folinic Acid After High-Dose Methotrexate for Childhood Acute Lymphatic Leukemia That Will Prevent Neurotoxicity Without Rescuing Malignant Cells in the Central Nervous System :. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, vol.26, no.3, 156-163.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.